Four pioneering Geneva-based start-ups have received funding from the FONGIT Innovation Fund to drive innovation in the life sciences and ICT sectors.
The FONGIT Innovation Fund (FIF) has announced its latest round of funding, awarding a total of CHF 350,000 to four innovative start-ups based in Geneva. These projects, spanning life sciences and information and communication technology (ICT), were selected based on their potential social and economic impact, technical feasibility and innovative business models.
Alpes-éco Suisse: promoting free-range farming
Alpes-éco Suisse, a company specializing in connected devices for smart herd management, has been awarded a seed loan of CHF 100,000. The company’s technology aims to support the sustainability and efficiency of free-range farming, an essential practice for feeding over 2.5 billion people worldwide. By developing autonomous devices that improve flock management, Alpes-éco Suisse is making a significant environmental impact and supporting vital ecosystems. This funding will enable the company to further develop and expand its innovative solutions.
Adjust Medical: addressing mitral regurgitation
Adjust Medical, another recipient of a seed loan of CHF 100,000, is focused on developing a first-line therapy for primary mitral regurgitation (MR), a condition that affects nearly 2% of the population. The company’s approach preserves future treatment options and simplifies patient screening, addressing a critical gap in current medical interventions. The funding will support Adjust Medical’s mission to advance treatment and improve long-term outcomes for patients with MR.
Clee Medical: revolutionizing neurosurgery
Clee Medical, supported by the Wyss Center, received a seed loan of CHF 100,000 to further develop its AI-based visualization technology for neurosurgery. This innovative system provides ultra-high-resolution live navigation during brain surgery, improving patient safety and reducing complications. The funding will accelerate the deployment of this technology to make neurosurgery faster, safer and more effective.
Neurovia Bioelectronics: transforming blood pressure management
Neurovia Bioelectronics, an EPFL project based at the Campus Biotech in Geneva, was awarded a grant of CHF 50,000 for its breakthrough solution in blood pressure management. The company’s on-demand, minimally invasive technology addresses postural hypotension and other autonomic dysfunctions, with the potential to significantly improve patient outcomes. The grant will support the continued development and potential applications of this innovative solution.
